myocardial infarction epidemiology forecast insight

DelveInsight’s ‘Myocardial Infarction – Epidemiology Forecast—2034’ report delivers an in-depth understanding of Myocardial Infarction, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geography Covered

• The United States
• EU5
• Japan

Study Period: 2021-2034

Myocardial Infarction Disease Understanding

Myocardial Infarction (MI) is defined pathologically as myocardial cell death due to prolonged ischemia. Diminished cellular glycogen, and relaxed myofibrils and sarcolemmal disruption, are the first ultrastructural changes and are seen as early as 10–15 minutes after the onset of ischemia

Symptoms associated to Myocardial Infarction includes chest pain that may appear as a sensation of tightness or pressure initially. Pain radiates most often to the left arm, but may also radiate to the lower jaw, neck, right arm, back, and upper abdomen. Chest pain may be accompanied by sweating, nausea or vomiting, and fainting

The increasing use of cardiac biomarkers for diagnosing Myocardial Infarction during the past two decades and the changing cutoff levels for the laboratory tests used to define myocardial injury or Myocardial Infarction are the most apparent complicating factors in many studies of Myocardial Infarction trends.

Furthermore, the use of biomarkers has likely improved the ascertainment of Myocardial Infarction over time, which would have the dual effects of potentially masking actual reductions in disease incidence because of primary prevention efforts and leading to false improvements in MI-related case fatality attributable to the inclusion of smaller infarctions that previously would have been clinically unrecognized. 

Myocardial Infarction Epidemiology

The Myocardial Infarction epidemiology division provides insights into the historical and current patient pool and the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends and assumptions.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Myocardial Infarction epidemiology segmented as the Prevalent Cases of Myocardial Infarction, Gender-specific Prevalence of Myocardial Infarction, and Type-specific Prevalence of Myocardial Infarction. The report includes the prevalent Myocardial Infarction symptoms in the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), China, and Japan from 2021 to 2034.

Country-wise Myocardial Infarction Epidemiology

The epidemiology segment also provides the Myocardial Infarction epidemiology data and findings across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

• The total prevalent population of Myocardial Infarction in the 7MM was ~ 13,123,128 in 2020 and expected to increase for the study period, i.e., 2021-2034.
• As per the estimates, among the European countries, Germany had the highest prevalent population of Myocardial Infarction with ~1,653,683 cases, followed by France, which had a prevalent population of ~ 997,061 in 2020.

Scope of the Report

• Myocardial Infarction report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Myocardial Infarction Epidemiology Report and Model provide an overview of the risk factors and global trends of Myocardial Infarction in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report provides insight into the historical and forecasted patient pool of Myocardial Infarction in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Myocardial Infarction
• The report provides the segmentation of the Myocardial Infarction epidemiology by Prevalent Cases of Myocardial Infarction in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report provides the segmentation of the Myocardial Infarction epidemiology by severity-specific Prevalent Cases of Myocardial Infarction in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan

Report Highlights

• 10-year Forecast of Myocardial Infarction epidemiology
• 7MM Countries Coverage
• Total Prevalent Cases of Myocardial Infarction
• Prevalent Cases according to segmentation: Gender-specific Prevalence of Myocardial Infarction and Type-specific Prevalence of Myocardial Infarction

KOL Views

We interview KOLs, and SME’s opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about Myocardial Infarction?
• What are the key findings of Myocardial Infarction epidemiology across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan, and which type will have the highest number of patients during the forecast period (2021-2034)?
• What would be the total number of patients with Myocardial Infarction across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan during the forecast period (2021-2034)?
• At what CAGR the patient population is expected to grow during the forecast period (2021-2034)?
• What are the disease risk, burden, and unmet needs of Myocardial Infarction?
• What are the currently available treatments for Myocardial Infarction?

Reasons to buy

The Myocardial Infarction Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Myocardial Infarction market
• Quantify patient populations in the global Myocardial Infarction market to improve product design, pricing, and launch plans
• Understand the magnitude of the Myocardial Infarction population by its Prevalence cases
• Understand the magnitude of the Myocardial Infarction population by its Gender-specific cases
• Understand the magnitude of the Myocardial Infarction population by its Type-specific cases
• The Myocardial Infarction epidemiology report and model was written and developed by Masters and PhD level epidemiologists
• The Myocardial Infarction Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population